FDA clears first single-biomarker blood test for Alzheimer’s: 4…
On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule-out (negative result) assessment of amyloid pathology …